Literature DB >> 5662012

Kinetics of the reaction of renin with nine synthetic peptide substrates.

L T Skeggs, K E Lentz, J R Kahn, H Hochstrasser.   

Abstract

A number of peptides have been synthesized which represent portions of the tetradecapeptide renin substrate molecule, and which contain the hydrolyzable leu-leu bond. An automatic chemical method for determination of the velocity of the reaction of renin with these compounds was developed. Application of the method at several levels of substrate concentration permitted construction of Lineweaver-Burk plots, and calculation of Michaelis constants (K(m)) and maximal velocities (V(max)). The results show that the maximum affinity of the enzyme (lowest K(m)) for substrate is achieved only with the full tetradecapeptide molecule (asp(1)-arg(2)-val(3)-tyr(4)-ileu(5)-his(6)-pro(7)-phe(8)-his(9)-leu(10)-leu(11)-val(12)-tyr(13)-ser(14)). Removal of asp(1) and arg(2) from the N-terminal increases the K(m) eight-fold. Further, moderate increase in K(m) occurs when the next amino acids, val(3), tyr(4) and ileu(5), are removed. The further removal of his(6) results in a marked reduction in the V(max). Removal of ser(14) from the C-terminal of the nonapeptide his(6)-pro(7)-phe(8)-his(9)-leu(10)-leu(11)-val(12)-tyr(13)-ser(14) does not greatly affect the K(m) nor the V(max). Further removal of tyr(13) from this compound results in complete loss of substrate activity. It is suggested that the compounds his(6)-pro(7)-phe(8)-his(9)-leu(10)-leu(11)-val(12)-tyr(13)-ser(14) or his(6)-pro(7)-phe(8)-his(9)-leu(10)-leu(11)-val(12)-tyr(13) might be used as substrates for the chemical assay and standardization of renin.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5662012      PMCID: PMC2138508          DOI: 10.1084/jem.128.1.13

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  8 in total

1.  Amino-acid sequence in a hypertensin.

Authors:  D F ELLIOTT; W S PEART
Journal:  Nature       Date:  1956-03-17       Impact factor: 49.962

2.  A simple method for the extraction and partial purification of renin.

Authors:  E HAAS; H LAMFROM; H GOLDBLATT
Journal:  Arch Biochem Biophys       Date:  1954-02       Impact factor: 4.013

3.  Studies on the preparation and properties of renin.

Authors:  L T Skeggs; K E Lentz; J R Kahn; H Hochstrasser
Journal:  Circ Res       Date:  1967-07       Impact factor: 17.367

4.  Synthesis and biological activities of a tetradecapeptide renin substrate.

Authors:  D Montague; B Riniker; H Brunner; F Gross
Journal:  Am J Physiol       Date:  1966-03

5.  THE SYNTHESIS OF 9-CITRULLINE, 9-HISTIDINE, AND 9-DESARGININE BRADYKININ.

Authors:  H A DEWALD; E D NICOLAIDES
Journal:  J Med Chem       Date:  1964-01       Impact factor: 7.446

6.  The preparation, purification, and amino acid sequence of a polypeptide renin substrate.

Authors:  L T SKEGGS; J R KAHN; K LENTZ; N P SHUMWAY
Journal:  J Exp Med       Date:  1957-09-01       Impact factor: 14.307

7.  The synthesis of a tetradecapeptide renin substrate.

Authors:  L T SKEGGS; K E LENTZ; J R KAHN; N P SHUMWAY
Journal:  J Exp Med       Date:  1958-09-01       Impact factor: 14.307

8.  The purification and partial characterization of several forms of hog renin substrate.

Authors:  L T SKEGGS; K E LENTZ; H HOCHSTRASSER; J R KAHN
Journal:  J Exp Med       Date:  1963-07       Impact factor: 14.307

  8 in total
  8 in total

Review 1.  Renin inhibitors.

Authors:  W J Greenlee
Journal:  Pharm Res       Date:  1987-10       Impact factor: 4.200

Review 2.  [Renin-angiotensin-aldosterone system from the pathophysiological viewpoint].

Authors:  C Werning; W Siegenthaler
Journal:  Klin Wochenschr       Date:  1969-12-01

Review 3.  Renin inhibition.

Authors:  H D Kleinert
Journal:  Cardiovasc Drugs Ther       Date:  1995-10       Impact factor: 3.727

Review 4.  The clinical potential of renin inhibitors and angiotensin antagonists.

Authors:  R J Cody
Journal:  Drugs       Date:  1994-04       Impact factor: 9.546

5.  A radiochemical renin assay.

Authors:  F A Mendelsohn; C I Johnston
Journal:  Biochem J       Date:  1971-01       Impact factor: 3.857

6.  Inhibition of renin by conformationally restricted analogues of angiotensinogen.

Authors:  C R Nakaie; M C Oliveira; L Juliano; A C Paiva
Journal:  Biochem J       Date:  1982-07-01       Impact factor: 3.857

Review 7.  Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review.

Authors:  R J Cody
Journal:  Drugs       Date:  1984-08       Impact factor: 9.546

8.  Angiotensin 1-7 Receptor and Angiotensin II Receptor 2 Blockades Prevent the Increased Serum and Kidney Nitric Oxide Levels in Response to Angiotensin II Administration: Gender-Related Difference.

Authors:  Tahereh Safari; Mehdi Nematbakhsh
Journal:  Int J Prev Med       Date:  2013-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.